Ryan Dorton
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 5
-
- Cancer therapeutics and mechanisms 3
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Christopher P. Leamon (17 shared papers)Joseph A. Reddy (17 shared papers)Marilynn Vetzel (15 shared papers)Elaine Westrick (9 shared papers)Iontcho R. Vlahov (12 shared papers)Nikki Parker (4 shared papers)Paul J. Kleindl (4 shared papers)Melissa Nelson (10 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Molecular Pharmaceutics (2 papers)Bioconjugate Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Ryan Dorton
18 papers receiving 653 citations
Peers
Comparison fields: 5 of 69
- Biomaterials 130
- Oncology 219
- Radiology, Nuclear Medicine and Imaging 137
- Biotechnology 51
- Organic Chemistry 159
Countries citing papers authored by Ryan Dorton
This map shows the geographic impact of Ryan Dorton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Dorton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Dorton more than expected).
Fields of papers citing papers by Ryan Dorton
This network shows the impact of papers produced by Ryan Dorton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Dorton. The network helps show where Ryan Dorton may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Dorton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 145 | |
| 2 | 2007 | 89 | |
| 3 | 2008 | 81 | |
| 4 | 2008 | 56 | |
| 5 | 2014 | 54 | |
| 6 | 2009 | 54 | |
| 7 | 2010 | 41 | |
| 8 | 2018 | 33 | |
| 9 | 2019 | 27 | |
| 10 | 2006 | 25 | |
| 11 | 2014 | 23 | |
| 12 | 2016 | 16 | |
| 13 | 2017 | 10 | |
| 14 | 2014 | 7 | |
| 15 | 2013 | 6 | |
| 16 | 2012 | 2 | |
| 17 | Folate receptor targeted anti-tumor activity of EC-0225, a folate-targeted dual drug conjugate | 2006 | 1 |
| 18 | 2011 | 1 |
About Ryan Dorton
Ryan Dorton is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 671 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Folate and B Vitamins Research (4 papers), Cancer Research and Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Glycosylation and Glycoproteins Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Biomaterials (130 citations), Oncology (219 citations), Radiology, Nuclear Medicine and Imaging (137 citations), Biotechnology (51 citations) and Organic Chemistry (159 citations). Ryan Dorton has collaborated with scholars based in United States. Frequent co-authors include Christopher P. Leamon, Joseph A. Reddy, Marilynn Vetzel, Elaine Westrick, Iontcho R. Vlahov, Nikki Parker, Paul J. Kleindl, Melissa Nelson, Hari Krishna R. Santhapuram and Le-Cun Xu. Their work appears in journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmaceutics, Bioconjugate Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.